GEVO Form 4: CFO Disposes 57,651 Shares at ~$1.63

Rhea-AI Filing Summary

Agiri Oluwagbemileke Yusuf, CFO of Gevo, Inc. (GEVO), reported the sale of 57,651 shares of Gevo common stock on 08/20/2025 at a weighted average price of $1.6295 per share. After the reported disposition, the filing shows the reporting person beneficially owns 277,835 shares directly and holds an additional 18,977.57 shares indirectly through a 401(k) plan. The footnote clarifies the sale occurred in multiple transactions at prices ranging from $1.625 to $1.635 per share. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Transparent disclosure of insider sale with weighted-average price and execution range provided
• Significant retained ownership: reporting person still beneficially owns 277,835 shares directly
• Additional indirect holdings disclosed: 18,977.57 shares held via a 401(k) plan

Negative

• Insider disposition of 57,651 shares on 08/20/2025 which reduces direct holdings
• No context provided on percentage of outstanding shares or rationale for sale, limiting interpretation

Insights

Corporate Governance Expert

TL;DR: Routine insider sale disclosed; ownership remains material and disclosure is compliant with Section 16 reporting.

The filing documents a standard Section 16 sale by the company's CFO rather than a gift, option exercise, or complex derivative transaction. The reporting person retains meaningful direct ownership (277,835 shares) and additional indirect holdings via a 401(k), which suggests ongoing alignment with shareholder interests. The weighted-average price and price range disclosure align with Form 4 requirements and the footnote offers transparency on execution. No governance red flags or unusual transactional structures are apparent from this filing alone.

Securities Analyst

TL;DR: The sale is a discrete insider disposition; it provides limited signal about company fundamentals without additional context.

From a market-impact perspective, the transaction is a specific insider sale of 57,651 shares at ~$1.63 each. The filing does not indicate any derivative exercises or compensatory issuance tied to the sale. Because the report lacks context on total outstanding shares, timing rationale, or concurrent open-market activity by other insiders, the trade by itself is insufficient to infer a change in company outlook or material information. It is transparent and conforms to reporting norms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Agiri Oluwagbemileke Yusuf

(Last) (First) (Middle)

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

BUILDING C, SUITE 310

(Street)

ENGLEWOOD CO 80112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		S		57,651	D	$1.6295(1)	277,835	D
Common Stock								18,977.57	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.625 to $1.635 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ E. Cabell Massey, Attorney-in-Fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did GEVO CFO Agiri Yusuf report on Form 4?

The CFO reported selling 57,651 shares of Gevo common stock on 08/20/2025 at a weighted average price of $1.6295 per share.

How many Gevo shares does the reporting person own after the sale?

Directly owns 277,835 shares and indirectly holds 18,977.57 shares through a 401(k) plan according to the filing.

What price range did the shares sell within for the reported transaction?

The footnote states sales occurred at prices ranging from $1.625 to $1.635 per share.

Was the Form 4 signed by the reporting person?

The Form 4 was signed by an attorney-in-fact (E. Cabell Massey) on 08/21/2025 on behalf of the reporting person.

Does the filing show any derivative transactions or option exercises?

No. Table II for derivative securities contains no entries; only a non-derivative sale is reported.